Repurposing Ivermectin to augment chemotherapy's efficacy in osteosarcoma
B Hu, H Tan, L Yu, Q Liao… - Human & Experimental …, 2022 - journals.sagepub.com
Background Osteosarcoma is the most frequent malignant bone malignancy and the current
treatments are ineffective. Ivermectin, an anti-protozoal drug, has been shown to have anti …
treatments are ineffective. Ivermectin, an anti-protozoal drug, has been shown to have anti …
Repurposing Ivermectin to augment chemotherapy's efficacy in osteosarcoma
B Hu, H Tan, L Yu, Q Liao… - Human & experimental …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Osteosarcoma is the most frequent malignant bone malignancy and the current
treatments are ineffective. Ivermectin, an anti-protozoal drug, has been shown to have anti …
treatments are ineffective. Ivermectin, an anti-protozoal drug, has been shown to have anti …
Repurposing Ivermectin to augment chemotherapy's efficacy in osteosarcoma
B Hu, H Tan, L Yu, Q Liao… - Human and Experimental …, 2022 - ui.adsabs.harvard.edu
Background Osteosarcoma is the most frequent malignant bone malignancy and the current
treatments are ineffective. Ivermectin, an anti-protozoal drug, has been shown to have anti …
treatments are ineffective. Ivermectin, an anti-protozoal drug, has been shown to have anti …
Repurposing Ivermectin to augment chemotherapy's efficacy in osteosarcoma.
B Hu, H Tan, L Yu, Q Liao… - Human & Experimental …, 2022 - search.ebscohost.com
Background: Osteosarcoma is the most frequent malignant bone malignancy and the current
treatments are ineffective. Ivermectin, an anti-protozoal drug, has been shown to have anti …
treatments are ineffective. Ivermectin, an anti-protozoal drug, has been shown to have anti …
Repurposing Ivermectin to augment chemotherapy's efficacy in osteosarcoma.
B Hu, H Tan, L Yu, Q Liao, W Guo - Human & Experimental …, 2022 - europepmc.org
Background Osteosarcoma is the most frequent malignant bone malignancy and the current
treatments are ineffective. Ivermectin, an anti-protozoal drug, has been shown to have anti …
treatments are ineffective. Ivermectin, an anti-protozoal drug, has been shown to have anti …
Repurposing ivermectin to augment chemotherapy's efficacy in osteosarcoma.
B Hu, H Tan, L Yu, Q Liao, W Guo - 2022 - cabidigitallibrary.org
Background: Osteosarcoma is the most frequent malignant bone malignancy and the current
treatments are ineffective. Ivermectin, an anti-protozoal drug, has been shown to have anti …
treatments are ineffective. Ivermectin, an anti-protozoal drug, has been shown to have anti …